Institution profile

The Affiliated Cancer Hospital of Xiangya School of Medicine

Rank #231 · 4 unique linked submissions.

People

Top contributors

Poster Poster Program
BLUE RIBBON POSTER THERAPY: An Innovative Approach Using Ensemble Model Improves Risk Stratification of Ovarian Cancer: A Real World Cohort with PARP Inhibitor Maintaenance Treatment from China

Ovarian cancer, recognized as the most lethal gynecologic malignancy, is frequently detected at advanced stages and is associated with an unfavorable prognosis and heterogeneous therapeutic responses. Poly (ADP-ribose) polymerase inhibitors (PARPi) have revol...

Xian Xiong, PhDQianxi Ni, PhD
Therapy Physics